Corpus Intelligence IC Memo — FRANCISCAN BEACON HOSPITAL 2026-04-26 12:48 UTC
IC Memo — FRANCISCAN BEACON HOSPITAL
Investment Committee Memorandum | IN | 8 beds | Grade D | EBITDA uplift $578K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FRANCISCAN BEACON HOSPITAL

CCN 150191 | LA PORTE, IN | 8 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

FRANCISCAN BEACON HOSPITAL is a 8-bed under-performing / distressed in LA PORTE, IN with $7.7M in net patient revenue and a -43.4% operating margin. The hospital serves a payer mix of 44.7% Medicare, 8.8% Medicaid, and 46.5% commercial.

Thesis: Turnaround. Our ML models identify $578K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -43.4% to -35.9% (+747bps).

Net Revenue HCRIS$7.7M
Current EBITDA COMPUTED$-3.4M
Operating Margin COMPUTED-43.4%
Occupancy HCRIS3.9%
Revenue / Bed COMPUTED$968K
Net-to-Gross HCRIS22.5%
Distress Probability ML59.8%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
16
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -43.4% places it below the state median. Among 16 size-comparable peers (4-16 beds), the median margin is -50.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (4-16), prioritizing same-state peers. 16 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FRANCISCAN BEACON HOSPITAL (Target)IN8$7.7M-43.4%
FRANCISCAN HEALTH HAMMONDIN10$117.7M-4.3%
PHYSICIANS MEDICAL CENTERIN10$60.0M24.9%
OAKLAWN PSYCHIATRIC CENTER ININ16$37.1M-50.0%
HAMILTON CENTER INC.IN16$30.8M-50.0%
IU HEALTH FRANKFORT HOSPITALIN12$29.3M3.0%
4C HEALTHIN16$27.8M-6.3%
IU HEALTH BLACKFORD HOSPITALIN15$23.9M-15.9%
REGIONAL MENTAL HEALTH CENTERIN16$23.8M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $578K (747bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$163K+210bp18mo
Denial Rate Reduction12.0%6.5%$157K+203bp12mo
Cost to Collect4.5%2.5%$155K+200bp12mo
A/R Days Reduction5200.0%3800.0%$94K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+12bp6mo

5. EBITDA Bridge

Net Collection Rate
$163K
Denial Rate Reduction
$157K
Cost to Collect
$155K
A/R Days Reduction
$94K
Clean Claim Rate
$10K
Total EBITDA Uplift$578K
Current EBITDA$-3.4M
+ RCM Uplift+$578K
Pro Forma EBITDA$-2.8M
Current Margin-43.4%
Pro Forma Margin-35.9%
WC Released (1x)$297K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-5.2M$-16.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-5.2M$-19.7M0.00x-100.0%
Bull Case9.0x11.0x$-4.7M$-19.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.7M$-22.6M0.00x-100.0%
Bear Case11.0x10.0x$-5.7M$-17.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-5.7M$-21.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 3.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 59.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 16 hospitals with 4-16 beds
  • Same-state prioritization (n=17)
  • Comp margins: P25=-50.0% / P50=-50.0% / P75=-5.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.